Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Goebel

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Annali Dell'Istituto Superiore Di Sanita|July 23, 2004
Impact of stage differentiation on diagnosis of toxoplasmosisUwe Gross, Mathias Holpert, Stefan Goebel
Der Nervenarzt|March 20, 2024
[Clinical characteristics and diagnostics of human spongiform encephalopathies: an update]Peter Hermann, Stefan Goebel, Inga Zerr
Physiological Measurement|January 19, 2017
Adapting smartphone-based photoplethysmograpy to suboptimal scenariosAugusto Garcia-Agundez, Tim Dutz, Stefan Goebel
Viruses|February 26, 2022
Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's DiseasePeter Hermann, Philip Haller, Stefan Goebel, et al.
Neuroepidemiology|December 12, 2023
Effect of SARS-CoV-2 Incidence and Immunisation Rates on Sporadic Creutzfeldt-Jakob Disease IncidencePeter Hermann, Julia Böhnke, Timothy Bunck, et al.
Emerging Infectious Diseases|July 21, 2020
Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993-2018Peter Hermann, Johannes Treig, Steffen Unkel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2020
A prognostic model for overall survival in sporadic Creutzfeldt-Jakob diseaseFranc Llorens, Nicole Rübsamen, Peter Hermann, et al.
Journal of Neurology|November 9, 2019
Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3Franc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
European Journal of Neurology|February 25, 2022
Plasma neurofilament light chain as a biomarker for fatal familial insomniaPeter Hermann, Sezgi Canaslan, Anna Villar-Piqué, et al.
Annals of Clinical and Translational Neurology|July 17, 2018
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJDNatalia Ermann, Piotr Lewczuk, Matthias Schmitz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Annali Dell'Istituto Superiore Di Sanita|July 23, 2004
Impact of stage differentiation on diagnosis of toxoplasmosisUwe Gross, Mathias Holpert, Stefan Goebel
Der Nervenarzt|March 20, 2024
[Clinical characteristics and diagnostics of human spongiform encephalopathies: an update]Peter Hermann, Stefan Goebel, Inga Zerr
Physiological Measurement|January 19, 2017
Adapting smartphone-based photoplethysmograpy to suboptimal scenariosAugusto Garcia-Agundez, Tim Dutz, Stefan Goebel
Viruses|February 26, 2022
Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's DiseasePeter Hermann, Philip Haller, Stefan Goebel, et al.
Neuroepidemiology|December 12, 2023
Effect of SARS-CoV-2 Incidence and Immunisation Rates on Sporadic Creutzfeldt-Jakob Disease IncidencePeter Hermann, Julia Böhnke, Timothy Bunck, et al.
Emerging Infectious Diseases|July 21, 2020
Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993-2018Peter Hermann, Johannes Treig, Steffen Unkel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2020
A prognostic model for overall survival in sporadic Creutzfeldt-Jakob diseaseFranc Llorens, Nicole Rübsamen, Peter Hermann, et al.
Journal of Neurology|November 9, 2019
Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3Franc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
European Journal of Neurology|February 25, 2022
Plasma neurofilament light chain as a biomarker for fatal familial insomniaPeter Hermann, Sezgi Canaslan, Anna Villar-Piqué, et al.
Annals of Clinical and Translational Neurology|July 17, 2018
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJDNatalia Ermann, Piotr Lewczuk, Matthias Schmitz, et al.
Pageof 2